BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 17622583)

  • 1. Histone deacetylase inhibitors regulate retinoic acid receptor beta expression in neuroblastoma cells by both transcriptional and posttranscriptional mechanisms.
    De los Santos M; Zambrano A; Sánchez-Pacheco A; Aranda A
    Mol Endocrinol; 2007 Oct; 21(10):2416-26. PubMed ID: 17622583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined effects of retinoic acid and histone deacetylase inhibitors on human neuroblastoma SH-SY5Y cells.
    De los Santos M; Zambrano A; Aranda A
    Mol Cancer Ther; 2007 Apr; 6(4):1425-32. PubMed ID: 17431121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperacetylation enhances the growth-inhibitory effect of all-trans retinoic acid by the restoration of retinoic acid receptor beta expression in head and neck squamous carcinoma (HNSCC) cells.
    Whang YM; Choi EJ; Seo JH; Kim JS; Yoo YD; Kim YH
    Cancer Chemother Pharmacol; 2005 Nov; 56(5):543-55. PubMed ID: 15959780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor beta2 promoter in breast cancer cells.
    Sirchia SM; Ferguson AT; Sironi E; Subramanyan S; Orlandi R; Sukumar S; Sacchi N
    Oncogene; 2000 Mar; 19(12):1556-63. PubMed ID: 10734315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic patterns of the retinoic acid receptor beta2 promoter in retinoic acid-resistant thyroid cancer cells.
    Cras A; Darsin-Bettinger D; Balitrand N; Cassinat B; Soulié A; Toubert ME; Delva L; Chomienne C
    Oncogene; 2007 Jun; 26(27):4018-24. PubMed ID: 17213810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoic acids and trichostatin A (TSA), a histone deacetylase inhibitor, induce human pyruvate dehydrogenase kinase 4 (PDK4) gene expression.
    Kwon HS; Huang B; Ho Jeoung N; Wu P; Steussy CN; Harris RA
    Biochim Biophys Acta; 2006; 1759(3-4):141-51. PubMed ID: 16757381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth inhibitory retinoid effects after recruitment of retinoid X receptor beta to the retinoic acid receptor beta promoter.
    Cheung B; Yan J; Smith SA; Nguyen T; Lee M; Kavallaris M; Norris MD; Haber M; Marshall GM
    Int J Cancer; 2003 Jul; 105(6):856-67. PubMed ID: 12767074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of retinoic acid receptor beta gene expression is linked to aberrant histone H3 acetylation in lung cancer cell lines.
    Suh YA; Lee HY; Virmani A; Wong J; Mann KK; Miller WH; Gazdar A; Kurie JM
    Cancer Res; 2002 Jul; 62(14):3945-9. PubMed ID: 12124324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of neuroblastoma cells by phorbol esters and insulin-like growth factor 1 is associated with induction of retinoic acid receptor beta gene expression.
    Perez-Juste G; Aranda A
    Oncogene; 1999 Sep; 18(39):5393-402. PubMed ID: 10498893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesis.
    Petty WJ; Li N; Biddle A; Bounds R; Nitkin C; Ma Y; Dragnev KH; Freemantle SJ; Dmitrovsky E
    J Natl Cancer Inst; 2005 Nov; 97(22):1645-51. PubMed ID: 16288117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of retinoid and histone deacetylase inhibitor produced an anti-tumor effect in cutaneous T-cell lymphoma by restoring tumor suppressor gene, retinoic acid receptorβ2, via histone acetylation.
    Kato Y; Egusa C; Maeda T; Tsuboi R
    J Dermatol Sci; 2016 Jan; 81(1):17-25. PubMed ID: 26596218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid causes cell growth arrest and an increase in p27 in F9 wild type but not in F9 retinoic acid receptor beta2 knockout cells.
    Li R; Faria TN; Boehm M; Nabel EG; Gudas LJ
    Exp Cell Res; 2004 Mar; 294(1):290-300. PubMed ID: 14980522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous reactivation of the RARbeta2 tumor suppressor gene epigenetically silenced in breast cancer.
    Sirchia SM; Ren M; Pili R; Sironi E; Somenzi G; Ghidoni R; Toma S; Nicolò G; Sacchi N
    Cancer Res; 2002 May; 62(9):2455-61. PubMed ID: 11980632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo imaging of retinoic acid receptor beta2 transcriptional activation by the histone deacetylase inhibitor MS-275 in retinoid-resistant prostate cancer cells.
    Qian DZ; Ren M; Wei Y; Wang X; van de Geijn F; Rasmussen C; Nakanishi O; Sacchi N; Pili R
    Prostate; 2005 Jun; 64(1):20-8. PubMed ID: 15651062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic induction of folate receptor beta by all-trans retinoic acid and histone deacetylase inhibitors in acute myelogenous leukemia cells: mechanism and utility in enhancing selective growth inhibition by antifolates.
    Qi H; Ratnam M
    Cancer Res; 2006 Jun; 66(11):5875-82. PubMed ID: 16740727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel RARbeta isoform directed by a distinct promoter P3 and mediated by retinoic acid in breast cancer cells.
    Peng X; Maruo T; Cao Y; Punj V; Mehta R; Das Gupta TK; Christov K
    Cancer Res; 2004 Dec; 64(24):8911-8. PubMed ID: 15604252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of retinoic acid receptor beta2 target genes in F9 teratocarcinoma cells.
    Zhuang Y; Faria TN; Chambon P; Gudas LJ
    Mol Cancer Res; 2003 Jun; 1(8):619-30. PubMed ID: 12805409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4.
    Hayashi K; Goodison S; Urquidi V; Tarin D; Lotan R; Tahara E
    Int J Oncol; 2003 Mar; 22(3):623-9. PubMed ID: 12579317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Btg2 enhances retinoic acid-induced differentiation by modulating histone H4 methylation and acetylation.
    Passeri D; Marcucci A; Rizzo G; Billi M; Panigada M; Leonardi L; Tirone F; Grignani F
    Mol Cell Biol; 2006 Jul; 26(13):5023-32. PubMed ID: 16782888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct sensitivity of neuroblastoma cells for retinoid receptor agonists: evidence for functional receptor heterodimers.
    Carpentier A; Balitrand N; Rochette-Egly C; Shroot B; Degos L; Chomienne C
    Oncogene; 1997 Oct; 15(15):1805-13. PubMed ID: 9362447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.